Zhejiang Hisoar Pharmaceutical Co., Ltd.
Символ: 002099.SZ
SHZ
6.33
CNYРыночная цена сегодня
-24.3560
Коэффициент P/E
-0.1402
PEG Ratio
10.05B
Капитал MRK
- 0.01%
Доходность DIV
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099-SZ) финансовые отчеты
Балансовый отчет
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1420.6 | 1490.8 | 1837.4 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -10.7 | 390.7 | 9.5 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 477.7 | 625.6 | 627.3 | |||||||||||||||||||||
balance-sheet.row.inventory | 0 | 702.3 | 1102.4 | 908 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 25.2 | 26.8 | 64.3 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 2625.7 | 3245.7 | 3436.9 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3029.3 | 3097.5 | 2981.2 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 603.3 | 711 | 757.7 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 520.8 | 555.8 | 490.1 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1124.1 | 1266.8 | 1247.9 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 682.4 | 728.7 | 249.9 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 41.6 | 52.3 | 52.2 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 17 | 2.1 | 51.8 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 4894.4 | 5147.4 | 4583 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 7520.1 | 8393.1 | 8019.9 | |||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 603.3 | 995 | 1028.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1043.3 | 838.3 | 574.4 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 27.1 | 23.5 | 37.7 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 10.2 | 162.1 | 17.8 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 57.3 | 54.4 | 53.4 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.2 | 129.2 | 1.2 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 111.5 | 317.5 | 173.6 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 10.2 | 14 | 17.8 | |||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 1918.4 | 2288.2 | 1906.3 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1618.7 | 1618.7 | 1618.7 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 816.5 | 1329.6 | 1410.8 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 279.6 | 268.1 | 344.2 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2891.6 | 2891.6 | 2741.3 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5606.4 | 6108 | 6115 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7520.1 | 8393.1 | 8019.9 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | -4.6 | -3.1 | -1.4 | |||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 5601.7 | 6104.9 | 6113.6 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||
Total Investments | 0 | 671.7 | 720.9 | 259.4 | |||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 1053.5 | 1000.5 | 592.2 | |||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -367.1 | -490.4 | -1235.7 |
Отчет о движении денежных средств
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 86.1 | 93.9 | 319.7 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 336.5 | 294.2 | 256.6 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1.6 | -3.1 | 48.7 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 62.6 | 200.4 | 37.6 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -377.5 | -350.2 | -142 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -229.8 | -755 | -353.2 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -213.7 | -194.1 | 102.1 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 67.6 | 602 | 60.3 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -1.6 | -3.1 | 48.7 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.9 | -132.9 | 13.4 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -179.4 | -229.6 | -74.2 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 5.9 | 0.2 | 3.7 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -464.1 | -251.5 | -0.1 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5 | 2.5 | -3.7 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 12.3 | -30.6 | 3.7 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -620.3 | -509 | -70.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -1817 | -929 | -230 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 236.9 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -236.9 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -195.4 | -53.4 | -478.1 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 1890.6 | 1063.2 | 696.9 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -121.9 | 80.8 | -11.2 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 75.1 | -25.5 | -38.5 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -551 | -351.4 | 413.6 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1037 | 1588 | 1939.4 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1588 | 1939.4 | 1525.8 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 116.1 | 102.4 | 533.9 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -179.4 | -229.6 | -74.2 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -63.3 | -127.2 | 459.7 |
Строка отчета о прибылях и убытках
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2171.9 | 2704.1 | 2484.8 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1867.2 | 1983.9 | 1559.4 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 304.6 | 720.3 | 925.4 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -34 | 295.5 | 477.5 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 471 | 570 | 770.6 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2338.3 | 2553.9 | 2330 | |||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 68.1 | 33.5 | 33 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 37.8 | 36.5 | 21.9 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2 | -139.6 | 1 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -34 | 295.5 | 477.5 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -2 | -139.6 | 1 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 37.8 | 36.5 | 21.9 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 364.6 | 336.5 | 333 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -464.2 | 240.4 | 122 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -466.2 | 100.8 | 123 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -44.6 | 14.7 | 29.2 | |||||||||||||||||||||
income-statement-row.row.net-income | 0 | -420.1 | 88 | 95.2 |
Часто задаваемые вопросы
Что такое Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) общие активы?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) общие активы - 7520092953.000.
Какова годовая выручка предприятия?
Годовая выручка - N/A.
Какова норма прибыли компании?
Норма прибыли компании - 0.167.
Что такое свободный денежный поток компании?
Свободный денежный поток - -0.035.
Что такое норма чистой прибыли предприятия?
Норма чистой прибыли - -0.208.
Что такое общий доход компании?
Общая выручка - -0.232.
Что такое Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) чистая прибыль (чистый доход)?
Чистая прибыль (чистый доход) - -420055857.710.
Что такое общий долг компании?
Общий долг - 1053517327.000.
Что такое операционные расходы?
Операционные расходы - 471007099.000.
Какова цифра денежных средств компании?
Денежные средства предприятия - 0.000.